1. Home
  2. MBBC vs CURX Comparison

MBBC vs CURX Comparison

Compare MBBC & CURX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBBC
  • CURX
  • Stock Information
  • Founded
  • MBBC 1902
  • CURX 2018
  • Country
  • MBBC United States
  • CURX United States
  • Employees
  • MBBC N/A
  • CURX N/A
  • Industry
  • MBBC Banks
  • CURX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBBC Finance
  • CURX Health Care
  • Exchange
  • MBBC Nasdaq
  • CURX Nasdaq
  • Market Cap
  • MBBC 30.8M
  • CURX 29.7M
  • IPO Year
  • MBBC N/A
  • CURX 2025
  • Fundamental
  • Price
  • MBBC $10.40
  • CURX $0.71
  • Analyst Decision
  • MBBC
  • CURX
  • Analyst Count
  • MBBC 0
  • CURX 0
  • Target Price
  • MBBC N/A
  • CURX N/A
  • AVG Volume (30 Days)
  • MBBC 3.2K
  • CURX 2.7M
  • Earning Date
  • MBBC 11-22-2025
  • CURX 09-09-2025
  • Dividend Yield
  • MBBC N/A
  • CURX N/A
  • EPS Growth
  • MBBC N/A
  • CURX N/A
  • EPS
  • MBBC 0.02
  • CURX N/A
  • Revenue
  • MBBC $6,885,334.00
  • CURX N/A
  • Revenue This Year
  • MBBC N/A
  • CURX N/A
  • Revenue Next Year
  • MBBC N/A
  • CURX N/A
  • P/E Ratio
  • MBBC $720.05
  • CURX N/A
  • Revenue Growth
  • MBBC 1.92
  • CURX N/A
  • 52 Week Low
  • MBBC $6.42
  • CURX $3.61
  • 52 Week High
  • MBBC $12.00
  • CURX $8.60
  • Technical
  • Relative Strength Index (RSI)
  • MBBC 55.54
  • CURX N/A
  • Support Level
  • MBBC $10.32
  • CURX N/A
  • Resistance Level
  • MBBC $10.48
  • CURX N/A
  • Average True Range (ATR)
  • MBBC 0.04
  • CURX 0.00
  • MACD
  • MBBC -0.01
  • CURX 0.00
  • Stochastic Oscillator
  • MBBC 54.55
  • CURX 0.00

About MBBC Marathon Bancorp Inc. Common Stock

Marathon Bancorp Inc is a Wisconsin-chartered savings bank. It is a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the Company's revenues come from interest income on loans and debt securities.

About CURX Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.

Share on Social Networks: